These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 27385172)
1. Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions. Langer O J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S143-56. PubMed ID: 27385172 [TBL] [Abstract][Full Text] [Related]
2. Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues. Wulkersdorfer B; Wanek T; Bauer M; Zeitlinger M; Müller M; Langer O Clin Pharmacol Ther; 2014 Aug; 96(2):206-13. PubMed ID: 24682030 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery. Feng B; Varma MV; Costales C; Zhang H; Tremaine L Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286 [TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography-Based Pharmacokinetic Analysis To Assess Renal Transporter-Mediated Drug-Drug Interactions of Antimicrobial Drugs. Hernández-Lozano I; Mairinger S; Filip T; Löbsch M; Stanek J; Kuntner C; Bauer M; Zeitlinger M; Hacker M; Helbich TH; Wanek T; Langer O Antimicrob Agents Chemother; 2023 Mar; 67(3):e0149322. PubMed ID: 36786609 [TBL] [Abstract][Full Text] [Related]
6. Effects of Drug Transporters on Pharmacological Responses and Safety. Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905 [TBL] [Abstract][Full Text] [Related]
7. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models. Varma MV; El-Kattan AF J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans. Momper JD; Tsunoda SM; Ma JD J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S82-98. PubMed ID: 27385182 [TBL] [Abstract][Full Text] [Related]
9. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved. Li R; Barton HA; Varma MV Clin Pharmacokinet; 2014 Aug; 53(8):659-78. PubMed ID: 25056496 [TBL] [Abstract][Full Text] [Related]
10. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites. Patel M; Taskar KS; Zamek-Gliszczynski MJ J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox. Özvegy-Laczka C; Ungvári O; Bakos É Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706 [TBL] [Abstract][Full Text] [Related]
12. What do drug transporters really do? Nigam SK Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361 [TBL] [Abstract][Full Text] [Related]
13. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions. Chu X; Chan GH; Evers R J Pharm Sci; 2017 Sep; 106(9):2357-2367. PubMed ID: 28416420 [TBL] [Abstract][Full Text] [Related]
14. Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions. Maeda K Drug Metab Pharmacokinet; 2020 Feb; 35(1):76-88. PubMed ID: 31948854 [TBL] [Abstract][Full Text] [Related]
15. Transporter-Mediated Drug-Drug Interactions and Their Significance. Liu X Adv Exp Med Biol; 2019; 1141():241-291. PubMed ID: 31571167 [TBL] [Abstract][Full Text] [Related]
16. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction. Mao Q; Lai Y; Wang J Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376 [TBL] [Abstract][Full Text] [Related]
17. Role of Hepatic Drug Transporters in Drug Development. Liu H; Sahi J J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168 [TBL] [Abstract][Full Text] [Related]
18. Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography. Hernández Lozano I; Karch R; Bauer M; Blaickner M; Matsuda A; Wulkersdorfer B; Hacker M; Zeitlinger M; Langer O AAPS J; 2019 Apr; 21(4):61. PubMed ID: 31037511 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of drug transporter interactions in drug discovery and development. Lai Y; Sampson KE; Stevens JC Comb Chem High Throughput Screen; 2010 Feb; 13(2):112-34. PubMed ID: 20053160 [TBL] [Abstract][Full Text] [Related]
20. Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development. Lai Y; Hsiao P Curr Pharm Des; 2014; 20(10):1577-94. PubMed ID: 23789952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]